The interplay between bone and glucose metabolism

C Cipriani, L Colangelo, R Santori, M Renella… - Frontiers in …, 2020 - frontiersin.org
The multiple endocrine functions of bone other than those related to mineral metabolism,
such as regulation of insulin sensitivity, glucose homeostasis, and energy metabolism, have …

Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties

AK Picke, G Campbell, N Napoli… - Endocrine …, 2019 - ec.bioscientifica.com
The prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide, especially as a
result of our aging society, high caloric intake and sedentary lifestyle. Besides the well …

Pathophysiology and management of type 2 diabetes mellitus bone fragility

C Eller-Vainicher, E Cairoli, G Grassi… - Journal of Diabetes …, 2020 - Wiley Online Library
Individuals with type 2 diabetes mellitus (T2DM) have an increased risk of bone fragility
fractures compared to nondiabetic subjects. This increased fracture risk may occur despite …

Biochemical markers of bone fragility in patients with diabetes

C Meier, R Eastell, DD Pierroz, NE Lane… - The Journal of …, 2023 - academic.oup.com
Context The risk of fragility fractures is increased in both type 1 and type 2 diabetes.
Numerous biochemical markers reflecting bone and/or glucose metabolism have been …

The role of autophagy in bone homeostasis

YF Guo, T Su, M Yang, C Li, Q Guo… - Journal of Cellular …, 2021 - Wiley Online Library
Autophagy is an evolutionarily conserved intracellular process and is considered one of the
main catabolism pathways. In the process of autophagy, cells are digested nonselectively or …

Role of metformin on osteoblast differentiation in type 2 diabetes

L Jiating, J Buyun, Z Yinchang - BioMed research international, 2019 - Wiley Online Library
Metformin, an effective hypoglycemic, can modulate different points of malignant mass,
polycystic ovary syndrome (PCOS), cardiovascular diseases, tuberculosis, and nerve …

[HTML][HTML] Diabetes and bone

K Hygum, J Starup-Linde, BL Langdahl - Osteoporosis and sarcopenia, 2019 - Elsevier
Bone disease is a serious complication to diabetes. Patients with type 1 diabetes (T1D) and
type 2 diabetes (T2D) suffer from an increased risk of fracture, most notably at the hip …

The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: systematic review and meta‐analysis of observational studies

K Hidayat, X Du, MJ Wu, BM Shi - Obesity Reviews, 2019 - Wiley Online Library
Certain glucose‐lowering medications have been implicated in the risk of fracture. While
there is convincing evidence from randomized controlled trials (RCTs) that thiazolidinedione …

Metformin activates Wnt/β-catenin for the treatment of diabetic osteoporosis

X Huang, S Li, W Lu, L **ong - BMC Endocrine Disorders, 2022 - Springer
Background With the deepening of social aging, the incidence rate of osteoporosis and
diabetes continues to rise. More and more clinical studies show that diabetes is highly …

Clinical utility of bone markers in various diseases

MC Vlot, M Den Heijer, RT De Jongh, MG Vervloet… - Bone, 2018 - Elsevier
Measurements of bone markers (BMs) in peripheral blood or urine are a pivotal part of bone
research within modern clinical medicine. In recent years the use of BMs increased …